IRF1 and cancer: PD-L1 upregulation was found to be associated with increased expression of γH2AX (a DSB marker) and IRF-1 (a PD-L1 inducer) in clinical UC-associated dysplasia and colitic cancer tissues but not in SCRC tissues or the corresponding non-cancerous UC mucosa.